Akero Therapeutics Inc
NASDAQ:AKRO

Watchlist Manager
Akero Therapeutics Inc Logo
Akero Therapeutics Inc
NASDAQ:AKRO
Watchlist
Price: 54.65 USD Market Closed
Market Cap: 4.5B USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of AKRO.

The Intrinsic Value is calculated as the average of DCF and Relative values:

AKRO Intrinsic Value
Not Available
Base Case Scenario
Compare AKRO to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about AKRO?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Akero Therapeutics Inc

Current Assets 754.5m
Cash & Short-Term Investments 737.8m
Other Current Assets 16.7m
Non-Current Assets 251m
Long-Term Investments 250.5m
PP&E 552k
Current Liabilities 47.7m
Accounts Payable 20.4m
Accrued Liabilities 27.3m
Non-Current Liabilities 289k
Other Non-Current Liabilities 289k
Efficiency

Free Cash Flow Analysis
Akero Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Akero Therapeutics Inc

Revenue
0 USD
Operating Expenses
-330m USD
Operating Income
-330m USD
Other Expenses
37.2m USD
Net Income
-292.8m USD
Fundamental Scores

AKRO Profitability Score
Profitability Due Diligence

Akero Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

ROE is Increasing
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
hidden
Profitability
Score

Akero Therapeutics Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

AKRO Solvency Score
Solvency Due Diligence

Akero Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
hidden
Solvency
Score

Akero Therapeutics Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

AKRO Price Targets Summary
Akero Therapeutics Inc

Wall Street analysts forecast AKRO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AKRO is 64.26 USD with a low forecast of 54.54 USD and a high forecast of 114.45 USD.

Lowest
Price Target
54.54 USD
0% Downside
Average
Price Target
64.26 USD
18% Upside
Highest
Price Target
114.45 USD
109% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Akero Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for AKRO is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

AKRO Insider Trading
Buy and sell transactions by insiders

AKRO News

Other Videos